PC
Procyon Corporation
PCYN · OTC
$0.25 +0.00% (+$0.00)
1M +0.00%
Market Cap $2.03M
P/E Ratio -
Div. Yield -
ROE 14.39%
Bulios Fair Price
$0.22
12.0% downside
Current Price
$0.25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PCYN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
58 /100
Fair P/B 0.89x
EV/EBITDA 20.35x
P/S 0.41x
Growth
57 /100
Stable Book val. growth 4.43%
Rev. growth 11.29%
FCF growth N/A
Profitability
18 /100
Weak Op. margin 4.65%
Gross margin 45.83%
FCF margin 2.51%
Quality
15 /100
Poor ROA 10.65%
ROIC 15.40%
Asset turnover 1.56x
Debt
100 /100
Low Net debt/EBITDA -0.06x
Debt/Equity 0.14x
Current ratio 3.08x
Stability
33 /100
Unstable EPS volatility 261.50%
Beta -0.95x
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PCYN
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Justice W. Anderson
Employees
19
Headquarters
Oldsmar